These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19224232)

  • 1. Positron-emission tomography in gynaecologic malignancies.
    Maffione AM; Piva M; Tsamita CS; Nanni C; Castellucci P; Ambrosini V; Lopci E; Musto A; Rampin L; Grassetto G; Marzola MC; Massaro A; Cracco E; Al-Nahhas A; Fanti S; Rubello D
    Arch Gynecol Obstet; 2009 Oct; 280(4):521-8. PubMed ID: 19224232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET Assessment of Other Gynecologic Cancers.
    Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
    PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT in monitoring response to treatment in gynecological malignancies.
    Amit A; Person O; Keidar Z
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):17-22. PubMed ID: 23299090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in gynecologic cancer.
    Yen TC; Lai CH
    Semin Nucl Med; 2006 Jan; 36(1):93-104. PubMed ID: 16356798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
    Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG
    Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography-computed tomography imaging for malignancies in women.
    Viswanathan C; Bhosale PR; Shah SN; Vikram R
    Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET and PET-CT imaging of gynecological malignancies: present role and future promise.
    Basu S; Li G; Alavi A
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):75-96. PubMed ID: 19105709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT and radiotherapy in gynecological cancer.
    Caroli P; Fanti S
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):533-42. PubMed ID: 20927020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
    J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging in gynecologic malignancies.
    Kumar R; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1155-67, ix. PubMed ID: 15488564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
    Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
    Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
    Johnson GR; Zhuang H; Khan J; Chiang SB; Alavi A
    Clin Nucl Med; 2003 Oct; 28(10):815-20. PubMed ID: 14508272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utilization of PET scan in breast and gynaecologic cancers].
    Huglo D; Vinatier D
    Gynecol Obstet Fertil; 2004 Apr; 32(4):330-9. PubMed ID: 15123104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
    Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of fluorine-18 fluorodesoxyglycose-positron emission tomography for treatment monitoring in patients with soft tissue sarcomas.
    Kasper B; Hohenberger P; Strauss LG; Dimitrakopoulou-Strauss A
    Hell J Nucl Med; 2010; 13(1):40-4. PubMed ID: 20411170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
    Magné N; Chargari C; Vicenzi L; Gillion N; Messai T; Magné J; Bonardel G; Haie-Meder C
    Cancer Treat Rev; 2008 Dec; 34(8):671-81. PubMed ID: 18849119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.